Onyx Pharmaceuticals, Inc. Share Price
Equities
US6833991093
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2013 | Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen | RE |
2013 | Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost | RE |
1st Jan change | Capi. | |
---|---|---|
+4.87% | 109B | |
+10.86% | 105B | |
-0.38% | 22.25B | |
-11.83% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.59% | 16.85B | |
+4.20% | 13.76B | |
+35.33% | 12.46B |
- Stock Market
- Equities
- Stock